Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)

NCT04921553 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04921553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04921553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)
Lead sponsor
Centre Leon Berard
Phase
Observational
Overall status
Unknown status
Start date
June 22, 2021
Completion date
June 30, 2025
Enrollment
500 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

alk fusion protein expression, atic-alk fusion protein expression, bcr-fgfr1 fusion protein expression, braf gene rearrangement, cancer, cancer metastatic, col1a1-pdgfb fusion protein expression, fgfr2 gene translocation, fgfr3 gene translocation, gene fusion, ntrk family gene mutation, ntrk gene fusion overexpression, ntrk1 gene translocation, ret gene translocation, ros gene translocation, ros1 gene translocation